Headache associated with estrogen withdrawal (Q103862): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Cefaleia ou migrânea se desenvolvendo dentro de cinco dias após o consumo diário de estrogênio exógeno por três semanas ou mais, que foi interrompido (geralmente durante o intervalo sem pílula dos anticoncepcionais orais combinados ou após um curso de reposição ou suplementação de estrogênio). Ele se resolve espontaneamente em três dias, na ausência de consumo posterior. | |||
| description / en | description / en | ||
Headache or migraine developing within five days after daily consumption of exogenous estrogen for three weeks or longer, which has been interrupted (usually during the pill-free interval of combined oral contraceptives or following a course of replacement or supplementary estrogen). It resolves spontaneously within three days in the absence of further consumption. | |||
Revision as of 09:38, 17 August 2026
Headache or migraine developing within five days after daily consumption of exogenous estrogen for three weeks or longer, which has been interrupted (usually during the pill-free interval of combined oral contraceptives or following a course of replacement or supplementary estrogen). It resolves spontaneously within three days in the absence of further consumption.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_59764378 |
||
| English | Headache associated with estrogen withdrawal |
Headache or migraine developing within five days after daily consumption of exogenous estrogen for three weeks or longer, which has been interrupted (usually during the pill-free interval of combined oral contraceptives or following a course of replacement or supplementary estrogen). It resolves spontaneously within three days in the absence of further consumption. |
